Novartis AG — Director's Dealing 2020

Aug 14, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellular Biomedicine Group, Inc. (CBMG)
CIK: 0001378624
Period of Report: 2020-08-11

Reporting Person: NOVARTIS PHARMA AG (10% Owner)
Reporting Person: NOVARTIS AG (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1458257	Direct

Footnotes

F1: Novartis Pharma AG is the record holder of the securities reported herein. As the parent of Novartis Pharma AG, Novartis AG may be deemed to share beneficial ownership of these securities.